Cetera Investment Advisers’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Sell
62,906
-6,831
-10% -$158K ﹤0.01% 2574
2026
Q1
$1.43M Sell
69,737
-40,944
-37% -$923K ﹤0.01% 2582
2025
Q4
$2.62M Buy
110,681
+37,155
+51% +$904K ﹤0.01% 1984
2025
Q3
$1.83M Buy
73,526
+14,320
+24% +$308K ﹤0.01% 2252
2025
Q2
$1.36M Sell
59,206
-2,730
-4% -$63.2K ﹤0.01% 2121
2025
Q1
$1.39M Buy
61,936
+2,338
+4% +$54.3K ﹤0.01% 2005
2024
Q4
$1.17M Sell
59,598
-780
-1% -$15.5K ﹤0.01% 2064
2024
Q3
$1.1M Buy
60,378
+682
+1% +$13K ﹤0.01% 2056
2024
Q2
$1.04M Buy
59,696
+1,636
+3% +$29K ﹤0.01% 2056
2024
Q1
$1.14M Buy
+58,060
New +$1.23M ﹤0.01% 1964

Other funds holding PRVA

Cetera Investment Advisers's PRVA Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Privia Health (PRVA) stake by 9.8% in Q2 2026, selling an estimated $158K and leaving 62,906 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2574.

Cetera Investment Advisers first reported a position in PRVA in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.62M in Q4 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Cetera Investment Advisers held 62,906 shares of Privia Health worth $1.62M as of Q2 2026.
  • Cetera Investment Advisers sold 6,831 Privia Health shares in Q2 2026, an estimated $158K.
  • Privia Health made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2574 holding.
  • Cetera Investment Advisers first reported a position in Privia Health in Q1 2024 and has held it in 10 quarters since.
  • Cetera Investment Advisers's Privia Health position peaked at $2.62M in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.